Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May 6;20(6):47.
doi: 10.1007/s11864-019-0645-2.

Applications of Cardiac Computed Tomography in the Cardio-Oncology Population

Affiliations
Review

Applications of Cardiac Computed Tomography in the Cardio-Oncology Population

Michael E Layoun et al. Curr Treat Options Oncol. .

Abstract

The increased risk for cardiovascular events in aging cancer survivors and those undergoing certain chemotherapeutic treatments has raised concern for more rigorous screening and surveillance methods above that of the general population. At this time, there are limited guidelines for how to best manage this vulnerable cohort. Questions regarding timing of screening, choice of imaging modality and risk reduction strategies-especially in those patients with known atherosclerotic disease-remain to be elucidated. Over a decade of case series, retrospective studies and clinical trials have shed light on the evolving role of cardiac computed tomography (CT) in this population, of which there is a relative paucity of data regarding its potential utility in the specific cardio-oncology population. Focusing on ability of cardiac CT to evaluate multiple cardiac and vascular structures, provide diagnostic and prognostic information, as well as assist interventional and surgical colleagues in surgical/percutaneous valve replacement and revascularization strategies is the premise for this review.

Keywords: Cardiac computed tomography angiography; Cardiotoxicity; Coronary artery calcium score; Radiation-induced valvulopathy; Vasculotoxicity.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Potential applications of cardiac computed tomography in visualizing the entire spectrum of cardiovascular disease induced by cancer treatments.

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. - PubMed
    1. Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers. 2016;25(7):1029–36. - PMC - PubMed
    1. Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi JJ. Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease. Eur Heart J. 2014;35(10):612–23. - PMC - PubMed
    1. Moslehi JJ. Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med. 2016;375(15):1457–67. - PubMed
    1. Potts JE, Kwok CS, Rashid M, Mamas MA, Iliescu CA, Lopez Mattei JC, et al. Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States. 2018 - PubMed

MeSH terms